Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer

BACKGROUND: A subset of men with metastatic prostate cancer (mPC) responds to immune checkpoint inhibitors, and there is an unmet need to predict those most likely to benefit. We characterized circulating tumor cells (CTCs) for expression of immune checkpoint ligands in men with mPC as a non-invasiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomark Res
Main Authors: Zhang, Tian, Agarwal, Anika, Almquist, R. Garland, Runyambo, Daniella, Park, Sally, Bronson, Elizabeth, Boominathan, Rengasamy, Rao, Chandra, Anand, Monika, Oyekunle, Taofik, Healy, Patrick, McNamara, Megan A., Ware, Kathryn, Somarelli, Jason A., George, Daniel J., Armstrong, Andrew J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Rapid Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890610/
https://ncbi.nlm.nih.gov/pubmed/33602330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00267-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados